Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
7.78M
-
Shares change
-
+4.16M
-
Total reported value, excl. options
-
$315M
-
Value change
-
+$169M
-
Put/Call ratio
-
0.72
-
Number of buys
-
62
-
Number of sells
-
-14
-
Price
-
$40.44
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2014
88 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2014.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.78M shares
of 207M outstanding shares and own 3.75% of the company stock.
Largest 10 shareholders include Pentwater Capital Management LP (1.47M shares), FMR LLC (1.4M shares), WASATCH ADVISORS INC (1M shares), Polar Capital LLP (529K shares), PERCEPTIVE ADVISORS LLC (303K shares), VANGUARD GROUP INC (250K shares), Iguana Healthcare Management, LLC (200K shares), Visium Asset Management, LP (200K shares), EAM Investors, LLC (184K shares), and BlackRock Fund Advisors (175K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.